COMMUNIQUÉS West-GlobeNewswire

Atrion Reports 2017 Results for Fourth Quarter and Full Year

27/02/2018 - 22:30

ALLEN, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI ) announced today that for the fourth quarter of 2017 revenues were $34.0 million compared to $33.3 million in the same period of 2016, [...]

Capital Senior Living Corporation Reports Fourth Quarter and Full Year 2017 Results

27/02/2018 - 22:15

DALLAS, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior housing communities, today announced operating and financial [...]

Reata Provides Program Update on Phase 2 Rare Renal Clinical Trials

27/02/2018 - 22:15

First patient enrolled for all cohorts of PHOENIX First data from PHOENIX expected 2H18 Retained benefit analysis from Phase 2 portion of CARDINAL expected 3Q18 IRVING, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Reata [...]

Supernus Announces Record Full Year 2017 Financial Results, Exceeding Operating Earnings Guidance

27/02/2018 - 22:15

Fourth quarter 2017 total revenue of $88.4 million, a 42% increase over 2016, and fourth quarter 2017 net product sales of $86.3 million, a 41% increase over 2016. Fourth quarter 2017 operating earnings of $34.3 million [...]

FibroGen Reports Fourth Quarter and Full Year 2017 Financial Results

27/02/2018 - 22:11

Roxadustat U.S. Phase 3 Program in CKD Anemia Enrollment Completion and Data Readout in 2018 Pamrevlumab Phase 2 IPF Study Achieves Statistically Significant Attenuation of Lung Fibrosis as Measured by Quantitative HRCT [...]

GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results

27/02/2018 - 22:07

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today reported recent business progress and financial results for the fourth quarter and year ended [...]

K2M Group Holdings, Inc. to Participate in Four Investor Conferences in March

27/02/2018 - 22:05

LEESBURG, Va., Feb. 27, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

Humanigen Completes Exchange of Loan Obligations for Equity

27/02/2018 - 22:05

Company Transformation Continues, Focused on Making CAR-T Safer, Better, More Routine Lenzilumab Nears Start of Clinical Testing to Prevent Critical CAR-T-related Neurotoxicity BRISBANE, Calif., Feb. 27, 2018 (GLOBE [...]

Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE™ (meropenem and vaborbactam) in Patients with cUTI

27/02/2018 - 22:05

- VABOMERE demonstrated a greater numerical overall success rate vs piperacillin-tazobactam - VABOMERE safety profile comparable to piperacillin-tazobactam NEW HAVEN, Conn., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Melinta [...]

IRIDEX to Present at the 30th Annual Roth Conference

27/02/2018 - 22:05

MOUNTAIN VIEW, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX ) today announced the Company plans to participate in the upcoming 30 th Annual Roth Conference in Orange County, CA. IRIDEX’s [...]

TESARO Announces Fourth-Quarter and Full-Year 2017 Operating Results

27/02/2018 - 22:05

ZEJULA is the #1 PARP inhibitor for women with ovarian cancer in the U.S. 2017 ZEJULA ® net sales totaled $109 million during first nine months of commercial launch Focused clinical development program for niraparib in [...]

Wright Medical Group N.V. Reports 2017 Fourth Quarter and Full-Year Financial Results and Provides 2018 Annual Guidance

27/02/2018 - 22:05

Fourth Quarter 2017 Net Sales of $218 Million; Full-Year 2017 Net Sales of $745 Million Fourth Quarter 2017 Net Income From Continuing Operations of $27 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $ [...]

GenMark Diagnostics Reports Fourth Quarter and Full Year 2017 Results

27/02/2018 - 22:03

CARLSBAD, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK ), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]

Retrophin Reports Fourth Quarter and Full Year 2017 Financial Results

27/02/2018 - 22:01

Company gains alignment to proceed on Subpart H accelerated approval pathway for sparsentan in FSGS; Study start-up activities ongoing to initiate Phase 3 pivotal trial in second quarter of 2018 Clinical development of [...]

AveXis Reports Fourth Quarter and Full Year 2017 Financial and Operating Results

27/02/2018 - 22:01

– On track to request pre-BLA meeting with FDA in Q2 2018 – – Intends to initiate pivotal trial in SMA Type 1 in Europe and multi-national pre-symptomatic SMA study in the first half of 2018 – – Anticipates IND [...]

Teladoc Announces Full Year and Fourth Quarter 2017 Results

27/02/2018 - 22:01

2017 Revenue of $233.3 million, growth of 89%; 4Q 2017 Revenue of $77.1 million, growth of 106% Total Paid Membership of 23.2 million, growth of 33% 2017 Visits of 1,463,000, growth of 54%; 4Q 2017 Visits of 464,000, [...]

Achaogen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

27/02/2018 - 22:01

-- Plazomicin New Drug Application (NDA) accepted by U.S. Food and Drug Administration (FDA); June 25, 2018 set as PDUFA action date -- -- Orally-administered antibacterial candidate C-Scape achieved positive top-line [...]

Atara Biotherapeutics Announces Proposed Offering of Common Stock

27/02/2018 - 22:01

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

Endocyte Appoints Patrick Machado, J.D. to Its Board of Directors

27/02/2018 - 22:01

– Patrick Machado, Co-founder and Former Chief Business and Financial Officer of Medivation, Brings Significant Experience in Building Value in the Prostate Cancer Space – WEST LAFAYETTE, Ind., Feb. 27, 2018 (GLOBE [...]